Guardant Health
Hospitals & Physicians Clinics · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
505 Penobscot Dr, Redwood City, Californ...Phone Number
(855) 698-8887Website
www.guardant360cdx.comRevenue
$5.1 MillionIndustry
About Guardant Health
Guardant Health Org Chart
Clinical Laboratory Assistant
Is Guardant Health your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Guardant Health has new funding data
Website visits: Recent activity has been detected on your website
Check out if Guardant Health is spiking on competitors!
Check if Guardant Health has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Guardant Health
Product Launch: Get notified when Guardant Health launches new products
Click to see if Guardant Health had a recent Job posting/layoffs
Earning: See what the market has to say on Guardant Health recently announced quarterly report
Guardant Health, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Guardant Health as Masked Content
Find 3 more new buyers
Compare Similar Companies to Guardant Health
Compare insights from companies similar to Guardant Health, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Guardant Health is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.
What does this means?
Guardant Health is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about Guardant Health.
Guardant Health Tech Stack
A closer look at the technologies used by Guardant Health
Guardant Health News & Media
Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in...Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
Guardant360® CDx is a comprehensive genomic profiling blood test that provides critical information to help inform personalized treatment decisions for patients with advanced solid cancers The liquid biopsy test is also approved as a companion diagnostic for TAGRISSO® (osimertinib) in non-small cell lung cancer This is the first blood test to be approved by Singapore's Health Sciences Authority for comprehensive genomic profiling for all solid tumors SINGAPORE, May 30, 2023 /PRNewswire/ -- GuardGuardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced lung and breast cancer
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that UnitedHealthcare (UHC) now covers the Guardant360® CDx liquid biopsy test for patients enrolled in its commercial policies for all FDA-approved companion diagnostic indications. The test is used by oncologists as a companion diagnostic to assess if patients are eligible for a targeted therapy for advanced or metastatic breast or non-small cell lung cancer (NSCLC). TGuardant Health Receives Regulatory Approval for Guardant360 CDx in Japan
Guardant360® CDx is a comprehensive genomic profiling test which utilizes blood samples from patients with advanced solid cancers TOKYO, March 14, 2022 /PRNewswire/ -- The Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Guardant360® CDx, a liquid biopsy test for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with advanced solid cancers. The Guardant360 CDx test was also granted approval as a companion diagnostic to iden
Top Hospitals & Physicians Clinics Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Guardant Health
Guardant Health Inc is a company that operates in the Medical Specialists industry. It employs 50to99 people and has 5Mto10M of revenue. The company is headquartered in Redwood City, California.... Read More